Publications by authors named "Astha Vinay Nagar"
Article Synopsis
- Immune checkpoint inhibitors are changing how non-small cell lung cancer is treated, but they still have low effectiveness.
- A new approach called antibody-conjugated drug-loaded nanotherapeutics (ADN) combines immunotherapy with targeted therapy for better results.
- In tests, a specific ADN combining anti-CD47 and anti-PDL1 antibodies with a drug targeting the PI3K/AKT/mTOR pathway showed improved tumor-killing capabilities in mice compared to existing treatments.
